Legend Biotech Valuation
| LEGN Stock | USD 42.69 1.75 4.27% |
At this time, the firm appears to be undervalued. Legend Biotech Corp secures a last-minute Real Value of $51.16 per share. The latest price of the firm is $42.69. Our model forecasts the value of Legend Biotech Corp from analyzing the firm fundamentals such as Profit Margin of (0.67) %, return on equity of -0.28, and Current Valuation of 6.64 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Legend Biotech's valuation include:
Price Book 6.7292 | Enterprise Value 6.6 B | Enterprise Value Ebitda (15.34) | Price Sales 14.4381 | Forward PE 1000 |
Undervalued
Today
Please note that Legend Biotech's price fluctuation is very steady at this time. Calculation of the real value of Legend Biotech Corp is based on 3 months time horizon. Increasing Legend Biotech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Legend Biotech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Legend Stock. However, Legend Biotech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 42.69 | Real 51.16 | Target 88.36 | Hype 40.94 | Naive 40.7 |
The intrinsic value of Legend Biotech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Legend Biotech's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Legend Biotech Corp helps investors to forecast how Legend stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Legend Biotech more accurately as focusing exclusively on Legend Biotech's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Legend Biotech's intrinsic value based on its ongoing forecasts of Legend Biotech's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Legend Biotech's closest peers.
Legend Biotech Cash |
|
Legend Valuation Trend
Knowing Legend Biotech's actual value is paramount for traders when making sound investment determinations. Using both Legend Biotech's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Legend Biotech Total Value Analysis
Legend Biotech Corp is now forecasted to have valuation of 6.64 B with market capitalization of 7.51 B, debt of 328.67 M, and cash on hands of 791.26 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Legend Biotech fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.64 B | 7.51 B | 328.67 M | 791.26 M |
Legend Biotech Investor Information
About 51.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.92. Legend Biotech Corp had not issued any dividends in recent years. Based on the key indicators obtained from Legend Biotech's historical financial statements, Legend Biotech Corp is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Legend Biotech Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Legend Biotech has an asset utilization ratio of 15.42 percent. This suggests that the Company is making $0.15 for each dollar of assets. An increasing asset utilization means that Legend Biotech Corp is more efficient with each dollar of assets it utilizes for everyday operations.Legend Biotech Ownership Allocation
Legend Biotech Corp maintains a total of 183.45 Million outstanding shares. Over half of Legend Biotech's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Legend Biotech Profitability Analysis
The company reported the previous year's revenue of 285.14 M. Net Loss for the year was (518.25 M) with loss before overhead, payroll, taxes, and interest of (284.01 M).About Legend Biotech Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Legend Biotech Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Legend Biotech Corp based exclusively on its fundamental and basic technical indicators. By analyzing Legend Biotech's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Legend Biotech's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Legend Biotech. We calculate exposure to Legend Biotech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Legend Biotech's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 140.9 M | 148 M | |
| Pretax Profit Margin | (1.82) | (1.92) | |
| Operating Profit Margin | (1.54) | (1.62) | |
| Net Loss | (1.82) | (1.91) | |
| Gross Profit Margin | 0.49 | 0.52 |
Legend Biotech Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 176.1 M | |
| Forward Price Earnings | 1000 |
Legend Biotech Current Valuation Indicators
Legend Biotech's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Legend Biotech's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Legend Biotech, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Legend Biotech's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Legend Biotech's worth.When determining whether Legend Biotech Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Legend Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Legend Biotech Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Legend Biotech Corp Stock: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Legend Biotech Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend Biotech. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.92) | Revenue Per Share 2.851 | Quarterly Revenue Growth 0.669 | Return On Assets (0.12) | Return On Equity (0.28) |
The market value of Legend Biotech Corp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend Biotech's value that differs from its market value or its book value, called intrinsic value, which is Legend Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend Biotech's market value can be influenced by many factors that don't directly affect Legend Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.